Form D · Biotechnology
G1 Therapeutics, Inc.
Research Triangle Park, NC · CIK 0001560241
Offering snapshot reported Jul 1, 2016 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 27, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$46,999,999 → $50,000,000
- Reported investors20 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 1, 2016 | Amendment | $50,000,000 | $3,000,001vs May 11, 2016 | 21 | SEC filing |
| May 11, 2016 | Initial | $46,999,999 | No comparison | 20 | SEC filing |
| Feb 12, 2015 | Initial | $16,511,994 | No comparison | 10 | SEC filing |
| Jun 23, 2014 | Amendment | $12,597,221 | $6,289,076vs Oct 17, 2013 | 8 | SEC filing |
| Oct 17, 2013 | Initial | $6,308,145 | No comparison | 8 | SEC filing |
| Aug 23, 2013 | Amendment | $1,249,996 | $792,094vs Apr 18, 2013 | 6 | SEC filing |
| Apr 18, 2013 | Initial | $457,902 | No comparison | 5 | SEC filing |
| Oct 12, 2012 | Initial | $762,884 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-262918
Source: Form D, filed Jul 1, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Claudia A. Black | Executive |
| Frederic N. Eshelman | Director |
| Michael Gutch | Director |
| Peter Kolchinsky | Director |
| Ron Laufer | Director |
| Thomas K Laundon | Executive |
| Gregory Mossinghoff | Executive |
| Glenn Muir | Director |
| Seth A. Rudnick | Director |
| Christy Shaffer | Director |
| Norman Sharpless | Director |
| Jay Staun | Executive |
| Jay Strum | Executive |
| Timothy Sullivan | Director |
| Clay Thorp | Director |
| Mark A. Velleca | Director, Executive |
| Carol Webb | Director |
| Kwok Kin Wong | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
79 T.W. Alexander Drive 4401 Research Commons, Suite 105
Research Triangle Park, NC, 27709
Research Triangle Park, NC, 27709